VT News

Ngane Punivai

Ask VT AI
View News Summary
  • Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
  • Altria's Q3 earnings beat estimates, but shares fell on weak outlook and persistent category challenges in smokable and oral products.
  • US and China agree to a tactical trade truce, suspending port fees and reducing some tariffs, but key issues remain unresolved.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
  • Altria's Q3 earnings beat estimates, but shares fell on weak outlook and persistent category challenges in smokable and oral products.
  • US and China agree to a tactical trade truce, suspending port fees and reducing some tariffs, but key issues remain unresolved.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Ngane Punivai

Top Topics

Trending in U.S.

World

Sport